M. Rost's scientific contributions

Publication (1)

In Germany in 2011, the Act on the Reform of the Market for Medicinal Products – known as AMNOG – saw a substantial revision of pricing regulations for newly authorised pharmaceuticals come into effect. Since this time, pharmaceutical companies have been required to submit a dossier on product benefit when a new product is launched on the German ma...